Molecular genetics and epidemiology of cancer susceptibility
FP5 — Improving Human Research Potential
- Duration
- 2002-01-01 → 2005-12-31
- EU contribution
- €120,000
- Participants
- 1
- Scheme
- BUR
Lines connect the coordinator with its partners.
Project objective
The Institute of Clinical Pharmacology, University Medical Centre Charité, Humboldt University Berlin, offers pre-doc positions to study the importance of inherited genetic variations in genes that potentially modify cancer risk. The project will focus on the determination, detection and functional characterization of single nucleotide polymorphisms (SNP). The molecular genetic techniques used are automated PCR, real-time PCR, PCR-RFLP analysis, and automated sequence analysis. Rt-PCRs, western-blots as well as host-cell assays will be used to determine the functional importance of new SNPs. Moreover, the training will include an introduction to molecular epidemiological methods and statistics. The fellow will be involved in ongoing studies, but he/she is also welcome to analyze study samples of his/her own. The application should include a curriculum vitae and references from two academic referees. Good knowledge of the English or German language is indispensable.
Original text from CORDIS.
Participants
- HUMBOLDT-UNIVERSITAET BERLIN · BERLINCoordinatorGermany
Links
Data: CORDIS, © European Union